CAMP Q1 2019 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$84M-10.6% YoY

Gross Profit

$33M39.7% margin

Operating Income

$15M18.3% margin

Net Income

$11M13.3% margin

EPS (Diluted)

$0.33

QoQ Revenue Growth

-4.6%

Cash Flow

Operating Cash Flow

-$353,000

Free Cash Flow

-$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$604M

Total Liabilities

$398M

Stockholders' Equity

$206M

Cash & Equivalents

$257M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$94M	-10.6%
Gross Profit	$33M	$38M	-12.9%
Operating Income	$15M	$2M	+693.3%
Net Income	$11M	-$5M	+336.3%

Revenue Segments

Product

$64M76%

Application Subscriptions And Related Products And Other Services

$20M24%

Geographic Segments

UNITED STATES

$60M68%

E M E A

$12M14%

South America

$10M11%

Asia Pacific

$3M4%

CANADA

$3M3%